Close

CVS Health To Present At Upcoming Conferences

May 7, 2015 12:00 PM EDT

WOONSOCKET, R.I., May 7, 2015 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that executives from the company will present at two investor conferences in the month of May. Jon Roberts, executive vice president and president of CVS/caremark, will be speaking to investors at the 2015 Bank of America Merrill Lynch Health Care Conference on May 13, 2015, at approximately 11:40 a.m. EDT. Larry Merlo, president and chief executive officer, will be speaking to investors at the UBS Global Healthcare Conference on May 20, 2015, at approximately 9:30 a.m. EDT.

Audio webcasts of the presentations will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcasts, visit http://investors.cvshealth.com. The webcasts will be archived and available on the website for a one-year period following the presentations.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health.  Through its 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.  Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

 

 

Logo - http://photos.prnewswire.com/prnh/20140905/143455  

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-health-to-present-at-upcoming-conferences-300079111.html

SOURCE CVS Health Corporation



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

UBS